MULTICENTER COMPARATIVE STUDY BETWEEN NUTRITIONAL THERAPY ALONE AND ANTI-TNF-alpha MONOCLONAL ANTIBODY IN INDUCING AND MAINTAINING REMISSION IN PEDIATRIC CROHN`S DISEASE: A RANDOMIZED CONTROLLED TRIAL.
Phase of Trial: Phase III
Latest Information Update: 26 May 2012
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 26 May 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 04 Aug 2011 New trial record